Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to -$28.6 million.

  • Pediatrix Medical's Cash from Financing Activities fell 83005.54% to -$28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.8 million, marking a year-over-year decrease of 20709.23%. This contributed to the annual value of -$14.5 million for FY2024, which is 4367.1% up from last year.
  • Per Pediatrix Medical's latest filing, its Cash from Financing Activities stood at -$28.6 million for Q3 2025, which was down 83005.54% from -$4.3 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Cash from Financing Activities registered a high of $108.6 million during Q1 2023, and its lowest value of -$761.7 million during Q1 2021.
  • Over the past 5 years, Pediatrix Medical's median Cash from Financing Activities value was -$6.0 million (recorded in 2025), while the average stood at -$69.8 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 6300076.34% in 2022, then soared by 14233.34% in 2023.
  • Pediatrix Medical's Cash from Financing Activities (Quarter) stood at $825000.0 in 2021, then tumbled by 10559.27% to -$86.3 million in 2022, then surged by 94.5% to -$4.7 million in 2023, then fell by 4.55% to -$5.0 million in 2024, then plummeted by 475.5% to -$28.6 million in 2025.
  • Its last three reported values are -$28.6 million in Q3 2025, -$4.3 million for Q2 2025, and -$6.0 million during Q1 2025.